These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 34642899)

  • 1. Side-by-Side Comparison of uPAR-Targeting Optical Imaging Antibodies and Antibody Fragments for Fluorescence-Guided Surgery of Solid Tumors.
    Baart VM; van Manen L; Bhairosingh SS; Vuijk FA; Iamele L; de Jonge H; Scotti C; Resnati M; Cordfunke RA; Kuppen PJK; Mazar AP; Burggraaf J; Vahrmeijer AL; Sier CFM
    Mol Imaging Biol; 2023 Feb; 25(1):122-132. PubMed ID: 34642899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multimodal molecular imaging approach targeting urokinase plasminogen activator receptor for the diagnosis, resection and surveillance of urothelial cell carcinoma.
    Baart VM; van der Horst G; Deken MM; Bhairosingh SS; Schomann T; Sier VQ; van der Mark MH; Iamele L; de Jonge H; Resnati M; Mazar AP; Pelger RCM; van der Pluijm G; Kuppen PJK; Vahrmeijer AL; Sier CFM
    Eur J Cancer; 2021 Mar; 146():11-20. PubMed ID: 33561783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model.
    Christensen A; Juhl K; Persson M; Charabi BW; Mortensen J; Kiss K; Lelkaitis G; Rubek N; von Buchwald C; Kjær A
    Oncotarget; 2017 Feb; 8(9):15407-15419. PubMed ID: 28039488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts.
    Kurbegovic S; Juhl K; Sørensen KK; Leth J; Willemoe GL; Christensen A; Adams Y; Jensen AR; von Buchwald C; Skjøth-Rasmussen J; Ploug M; Jensen KJ; Kjaer A
    Theranostics; 2021; 11(15):7159-7174. PubMed ID: 34158842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.
    Yang L; Sajja HK; Cao Z; Qian W; Bender L; Marcus AI; Lipowska M; Wood WC; Wang YA
    Theranostics; 2013; 4(1):106-18. PubMed ID: 24396518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.
    Lwin TM; Murakami T; Miyake K; Yazaki PJ; Shivley JE; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2018 Apr; 25(4):1079-1085. PubMed ID: 29372363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-infrared-conjugated humanized anti-carcinoembryonic antigen antibody targets colon cancer in an orthotopic nude-mouse model.
    DeLong JC; Murakami T; Yazaki PJ; Hoffman RM; Bouvet M
    J Surg Res; 2017 Oct; 218():139-143. PubMed ID: 28985840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
    Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM
    Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Targeted NIR-II Probe for Image-Guided Brain Tumor Surgery.
    Kurbegovic S; Juhl K; Chen H; Qu C; Ding B; Leth JM; Drzewiecki KT; Kjaer A; Cheng Z
    Bioconjug Chem; 2018 Nov; 29(11):3833-3840. PubMed ID: 30296054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery.
    Boonstra MC; van Driel PB; van Willigen DM; Stammes MA; Prevoo HA; Tummers QR; Mazar AP; Beekman FJ; Kuppen PJ; van de Velde CJ; Löwik CW; Frangioni JV; van Leeuwen FW; Sier CF; Vahrmeijer AL
    Oncotarget; 2015 Jun; 6(16):14260-73. PubMed ID: 25895028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and Characterization of Novel Pan-Cancer Anti-uPAR Fluorescent Nanobodies as Tools for Image-Guided Surgery.
    Mateusiak Ł; Floru S; De Groof TWM; Wouters J; Declerck NB; Debie P; Janssen S; Zeven K; Puttemans J; Vincke C; Breckpot K; Devoogdt N; Hernot S
    Adv Sci (Weinh); 2024 Aug; 11(30):e2400700. PubMed ID: 38845188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humanized Anti-Carcinoembryonic Antigen Antibodies Brightly Target and Label Gastric Cancer in Orthotopic Mouse Models.
    Cox KE; Turner MA; Amirfakhri S; Lwin TM; Hosseini M; Ghosh P; Obonyo M; Murakami T; Hoffman RM; Yazaki PJ; Bouvet M
    J Surg Res; 2024 Jan; 293():701-708. PubMed ID: 37839102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of IGF-1R SPECT/CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507.
    Heskamp S; van Laarhoven HW; Molkenboer-Kuenen JD; Bouwman WH; van der Graaf WT; Oyen WJ; Boerman OC
    Mol Pharm; 2012 Aug; 9(8):2314-21. PubMed ID: 22747077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.
    Day KE; Sweeny L; Kulbersh B; Zinn KR; Rosenthal EL
    Mol Imaging Biol; 2013 Dec; 15(6):722-9. PubMed ID: 23715932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma.
    Napp J; Stammes MA; Claussen J; Prevoo HAJM; Sier CFM; Hoeben FJM; Robillard MS; Vahrmeijer AL; Devling T; Chan AB; de Geus-Oei LF; Alves F
    Int J Cancer; 2018 May; 142(10):2118-2129. PubMed ID: 29277891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery.
    Gutowski M; Framery B; Boonstra MC; Garambois V; Quenet F; Dumas K; Scherninski F; Cailler F; Vahrmeijer AL; Pèlegrin A
    Surg Oncol; 2017 Jun; 26(2):153-162. PubMed ID: 28577721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative fluorescence delineation of head and neck cancer with a fluorescent anti-epidermal growth factor receptor nanobody.
    van Driel PB; van der Vorst JR; Verbeek FP; Oliveira S; Snoeks TJ; Keereweer S; Chan B; Boonstra MC; Frangioni JV; van Bergen en Henegouwen PM; Vahrmeijer AL; Lowik CW
    Int J Cancer; 2014 Jun; 134(11):2663-73. PubMed ID: 24222574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody.
    Cox KE; Turner MA; Lwin TM; Amirfakhri S; Kelly KJ; Hosseini M; Ghosh P; Obonyo M; Hoffman RM; Yazaki PJ; Bouvet M
    Ann Surg Oncol; 2024 Sep; 31(9):6291-6299. PubMed ID: 38888861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting human prostate cancer with 111In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts.
    Lütje S; van Rij CM; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
    Contrast Media Mol Imaging; 2015; 10(1):28-36. PubMed ID: 24764162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.